Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety of Potential Paediatric Patients Treated With Idarucizumab: a Non-internventional Chart Review Study

NCT02798107 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.

NCT NCT02798107
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02798107 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety of Potential Paediatric Patients Treated With Idarucizumab: a Non-internventional Chart Review Study
Lead sponsor
Boehringer Ingelheim
Phase
Observational
Overall status
Withdrawn
Start date
May 20, 2019
Completion date
May 24, 2019
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hemorrhage